Actelion pharmaceutical companies switzerland. The company has 19 active Jul 1, 2023 · Actelion has a global alliance with Merck & Co, Inc. The company was established in 1997 and is headquartered in Allschwil, Switzerland. – history, company profile (overview) and corporate video Actelion Pharmaceuticals Ltd. Actelion Ltd ist ein Schweizer Pharmaunternehmen mit Hauptsitz in Allschwil, Kanton Basel-Landschaft. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. Our portfolio of PAH treatments covers the spectrum of disease, from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications. Actelion will now become part of the Janssen Pharmaceutical Companies of Johnson & Johnson. It operates as a Discovery, development, and commercialization of innovative treatments for orphan diseases. Actelion has raised $46M in funding from investors like Atlas Venture, 3i Group and TVM Capital. Headquartered in Allschwil, Actelion is part of the Johnson & Johnson Family of Companies. Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Actelion's first drug Tracleer®, an orally available dual endothelin receptor antagonist, has been approved as a therapy for pulmonary arterial hypertension. Jun 15, 2017 · Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. The company focuses on the development of treatments for pulmonary arterial hypertension (PAH). Actelion Shareholders to Receive $280 Per Actelion Share in All-Cash Tender Offer to be Launched by Johnson & Johnson and One Share of New R&D Company for Each Actelion Share as Stock Dividend Actelion R&D Unit to Spin Out into Standalone Company Based and Listed in Switzerland; New R&D Company to Continue Actelion’s Successful Culture of Innovation and Johnson & Johnson to Hold Substantial Find 168 researchers and browse 6 departments, publications, full-texts, contact details and general information related to Actelion Pharmaceuticals Ltd | Allschwil, Switzerland | Actelion Ltd ist ein Schweizer Pharmaunternehmen mit Hauptsitz in Allschwil, Kanton Basel-Landschaft. Actelion markets Tracleer in the United States, the European Union, Japan, Canada, Australia, and Switzerland. S. Actelion Pharmaceuticals Ltd. It focuses on the manufacture of drugs that treat rare and orphan diseases. [3] Actelion focuses on the manufacture of drugs that treat rare and orphan diseases. , part of the Johnson & Johnson Family of Companies, is a leader in the field of pulmonary arterial hypertension (PAH). The company was founded in 1997 and is headquartered in Allschwil, Switzerland. Its ground-breaking research and medicines have been a key contributor to improve the lives of people affected by pulmonary hypertension, and made Actelion an industry leader in this area. Actelion Pharmaceuticals Ltd (Actelion), a subsidiary of Johnson & Johnson, is a biopharmaceutical company, which discovers, develops and commercializes innovative treatments for diseases with considerable unmet medical needs. Some of the drugs it has produced have been used to treat patients Headquartered in Allschwil, Actelion is part of the Johnson & Johnson Family of Companies. Actelion Pharmaceuticals Ltd. The acquisition was completed through an all-cash public tender offer by Johnson & Johnson ’s Swiss subsidiary, Janssen Holding GmbH, to acquire all publicly held shares of Actelion Ltd for $280 per share, payable in U. to discover, develop, and market new classes of renin inhibitors for patients with cardio-renal diseases. [2] The company is part of Johnson & Johnson Innovative Medicine business segment. Joaquin Duato, Johnson & Johnson’s Executive Vice President and Worldwide Chairman, Pharmaceuticals, answers six questions investors may have about the company’s acquisition of Actelion, a Swiss biopharmaceutical company. is a pharmaceutical and biotechnology company, headquartered in Allschwil, Switzerland. . Actelion Ltd is a Switzerland-based biopharmaceutical Company that focuses on the discovery, development and commercialization of treatments. May 12, 2014 · Actelion Pharmaceuticals Ltd. dollars. Explore how Johnson & Johnson Innovative Medicine applies rigorous science and patient-centered innovation to transform healthcare—with breakthrough treatments in oncology, immunology, neuroscience and beyond. Das Unternehmen ist spezialisiert auf Entwicklung und Vertrieb endothelbezogener Wirkstoffe. HISTORY Jul 14, 2025 · Actelion is an acquired company based in Allschwil (Switzerland), founded in 1997 by Jean Paul Clozel, Martine Clozel, Thomas Widmann and Walter Fischli. Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. butca, uhwt, 4536, k0hve, kre1r, 0dmnw, qbfq6, lrei, oi1qs, swc3w,